CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

STML's Net Income Growth by Quarter and Year

Stemline Therapeutics Inc's Net Income results by quarter and year



Select the Comparisons : Select the Ratio:                        

STML Net Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -21.75 -10.01 -10.18
III Quarter September - -16.06 -9.92 -9.23
II Quarter June - -15.46 -9.32 -10.15
I Quarter March -18.42 -14.57 -9.05 -7.68
FY   -18.42 -67.84 -38.30 -37.24



STML Net Income first quarter 2018 Y/Y Growth Comment
Stemline Therapeutics Inc in the first quarter recorded net loss of $ -18.42 millions.

According to the results reported in the first quarter, Stemline Therapeutics Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Stemline Therapeutics Inc' s Net Income no change of % ranks overall at the positon no. in the first quarter.




STML Net Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Stemline Therapeutics Inc's first quarter 2018 Net Income $ -18.42 millions STML's Income Statement
Stemline Therapeutics Inc's first quarter 2017 Net Income $ -14.57 millions Quarterly STML's Income Statement
New: More STML's historic Net Income Growth >>


STML Net Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Stemline Therapeutics Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


STML's I. Quarter Q/Q Net Income Comment
Although Stemline Therapeutics Inc in the I. Quarter 2018 showed net loss of $ -18.42 millions, it should be said, that this point to recovery in contrast to the -21.75 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry Stemline Therapeutics Inc achieved highest sequential Net Income growth. While Stemline Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Stemline Therapeutics Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Net Income 12 Months Ending $ -71.68 $ -67.83 $ -56.09 $ -49.96 $ -43.82
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Stemline Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -72 millions in the Mar 31 2018 period.
The business is getting worse as the cumulative net loss is inflating from $ -67.83 millions for the period from Dec 31 2017 to Mar 31 2017 and $ -21.75 millions for the twelve months ending in the quarter a year ago.

Stemline Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
STML's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for STML's Competitors
Net Income Growth for Stemline Therapeutics Inc's Suppliers
Net Income Growth for STML's Customers

You may also want to know
STML's Annual Growth Rates STML's Profitability Ratios STML's Asset Turnover Ratio STML's Dividend Growth
STML's Roe STML's Valuation Ratios STML's Financial Strength Ratios STML's Dividend Payout Ratio
STML's Roa STML's Inventory Turnover Ratio STML's Growth Rates STML's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2018
Luminex Corp  45.64 %$ 45.639 millions
Neurometrix, Inc.  44.11 %$ 44.109 millions
Baxter International Inc  43.01 %$ 43.015 millions
Tivity Health, Inc.  39.81 %$ 39.807 millions
Integrated Biopharma Inc  39.31 %$ 39.308 millions
Align Technology Inc  38.10 %$ 38.096 millions
United Therapeutics Corp  36.90 %$ 36.898 millions
Dentsply Sirona Inc.  35.85 %$ 35.846 millions
Mylan N.v.  31.17 %$ 31.175 millions
Idexx Laboratories Inc  29.57 %$ 29.566 millions
Jrsis Health Care Corp  27.75 %$ 27.754 millions
Kindred Healthcare, Inc  27.46 %$ 27.463 millions
Bruker Corp  26.27 %$ 26.267 millions
Resmed Inc  25.39 %$ 25.394 millions
Encompass Health Corp  24.64 %$ 24.645 millions
Stereotaxis, Inc.  23.56 %$ 23.561 millions
Cambrex Corp  21.11 %$ 21.107 millions
American Shared Hospital Services  19.93 %$ 19.926 millions
Biospecifics Technologies Corp  18.95 %$ 18.951 millions
Livanova Plc  17.76 %$ 17.762 millions
Mednax, Inc.  15.98 %$ 15.975 millions
Utah Medical Products Inc  15.72 %$ 15.724 millions
Addus Homecare Corp  14.06 %$ 14.064 millions
Artemis Therapeutics, Inc.  14.05 %$ 14.054 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OSN's Profile

Stock Price

OSN's Financials

Business Description

Fundamentals

Charts & Quotes

OSN's News

Suppliers

OSN's Competitors

Customers & Markets

Economic Indicators

OSN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071